News - Pfizer

Filter

Current filters:

Pfizer

Popular Filters

1 to 25 of 399 results

New indications approved in EU for Bristol-Myers/Pfizer Eliquis

New indications approved in EU for Bristol-Myers/Pfizer Eliquis

30-07-2014

The European Commission has approved US pharma majors Bristol-Myers Squibb and Pfizer’s Eliquis (apixaban)…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalRegulation

Earnings at Pfizer tank but still just beat expectations

Earnings at Pfizer tank but still just beat expectations

29-07-2014

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer posted a…

FinancialPfizerPharmaceuticalUSA

Puma Biotech rockets on new neratinib data; amends deal with Pfizer

Puma Biotech rockets on new neratinib data; amends deal with Pfizer

23-07-2014

US development-stage company Puma Biotechnology saw its share more than triple to $190 in after-hours…

BiotechnologyLicensingneratinibOncologyPB272PfizerPuma BiotechResearchTrastuzumabUSA

Seven pharma companies offer up compounds to UK researchers

Seven pharma companies offer up compounds to UK researchers

22-07-2014

UK researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds…

AstraZenecaEli LillyGlaxoSmithKlineJanssenMedical Research CouncilPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

Pfizer to acquire generics firm InnoPharma for up to $360 million

Pfizer to acquire generics firm InnoPharma for up to $360 million

17-07-2014

Having failed (so far) in its mega billion dollar ($116 billion) attempt to buy Anglo-Swedish drug major…

GenericsInnoPharmaMergers & AcquisitionsOncologyOphthalmicsPfizer

Pfizer’s BeneFIX reduces bleeding rates in Ph III study

Pfizer’s BeneFIX reduces bleeding rates in Ph III study

16-07-2014

US pharma giant Pfizer today released positive results of a Phase III study comparing a prophylaxis regimen…

BenefixHaemophiliaHematologyHemophilia BPfizerPharmaceuticalResearchSevere hemophilia BUSA

UK Business Secretary to set out new takeover rules

UK Business Secretary to set out new takeover rules

13-07-2014

UK Business Secretary Vince Cable is shortly to announce new regulations to deal with foreign takeover…

LegalMergers & AcquisitionsPfizerPharmaceuticalUKVince Cable

Varenicline combined with nicotine patch improves smoking cessation rates

Varenicline combined with nicotine patch improves smoking cessation rates

09-07-2014

Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective…

ChantixNeurologicalNicotinePfizerPharmaceuticalResearchSmoking cessationUSAVarenicline

England’s community prescribing rises almost 60% but costs increase only 15% in 10 years

England’s community prescribing rises almost 60% but costs increase only 15% in 10 years

09-07-2014

The number of prescription items dispensed in the community in England has increased by 58.5% over 10…

atorvastatinHealthcareLipitorPfizerPharmaceuticalUK

South Africa regulator gives MSF access to cheaper TB drug linezolid

South Africa regulator gives MSF access to cheaper TB drug linezolid

01-07-2014

After a three-year long struggle, humanitarian aid agency Medecins Sans Frontieres has received approval…

Antibiotics and Infectious diseasesGenericsHealthcareLinezolidPfizerRegulationSouth AfricaZyvox

Pfizer inks multi-million $ cancer immunology deal with Cellectis

Pfizer inks multi-million $ cancer immunology deal with Cellectis

18-06-2014

France-based genome engineering specialist Cellectis saw its shares rocket nearly 50% to 9.26 euros,…

CellectisLicensingMergers & AcquisitionsOncologyPfizerPharmaceutical

MRC Technology sells its melanocortin receptors program to Pfizer

MRC Technology sells its melanocortin receptors program to Pfizer

18-06-2014

UK-based technology transfer organization MRC Technology has sold its melanocortin receptors (MCRs) program,…

LicensingMRC TechnologyPfizerPharmaceutical

Pfizer agrees to pay $325 million over Neurontin

Pfizer agrees to pay $325 million over Neurontin

03-06-2014

US pharma giant Pfizer has agreed a $325 million settlement over a trial regarding the marketing of Neurontin…

CNS DiseasesLegalNeurontinPfizerPharmaceuticalUSA

Morris Birnbaum joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research

Morris Birnbaum joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research

30-05-2014

US pharma giant Pfizer has announced that Morris Birnbaum has joined the company as Chief Scientific…

BoardroomPfizerPharmaceuticalUSA

In Focus: Strong drivers will keep the pharma M&A pipeline bubbling

In Focus: Strong drivers will keep the pharma M&A pipeline bubbling

28-05-2014

The record start to 2014’s pharma M&A has been a welcome boost to a deal market that had been in the…

CancerGlobalInterviewsMergers & AcquisitionsPfizerPharmaceuticalPharmaceutical industryPharmaceutical sciences

AstraZeneca safe (for now?) as Pfizer walks away from pursuit of the firm

26-05-2014

US pharma giant Pfizer, which has been involved in a controversial pursuit of UK-based AstraZeneca, has…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

1 to 25 of 399 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top